RBP4 and early-onset autosomal dominant Alzheimer disease: Regarding the involvement of RBP4 in cognitive disorders, a biochemical analysis indicated that RBP4 is a potential biomarker involved in immunological and coagulation pathways in Alzheimer’s disease (33).